{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:26:10Z","timestamp":1759227970010},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12032-009-9257-1","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T17:04:56Z","timestamp":1245690296000},"page":"618-623","source":"Crossref","is-referenced-by-count":6,"title":["Bone marrow hyaluronan and reticulin in patients with malignant disorders"],"prefix":"10.1007","volume":"27","author":[{"given":"G.","family":"Sundstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hultdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Engstr\u00f6m-Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. M. S.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"key":"9257_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0609.1990.tb00344.x","volume":"44","author":"E L\u00f6fvenberg","year":"1990","unstructured":"L\u00f6fvenberg E, Wahlin A, Roos G, \u00d6st \u00c5. Reversal of myelofibrosis by hydroxyurea. Eur J Haematol. 1990;44:33\u20138.","journal-title":"Eur J Haematol"},{"key":"9257_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0268-960X(97)90022-9","volume":"11","author":"JT Reilly","year":"1997","unstructured":"Reilly JT. Idiopathic myelofibrosis: pathogenesis, natural history and management. Blood Rev. 1997;11:233\u201342. doi: 10.1016\/S0268-960X(97)90022-9 .","journal-title":"Blood Rev"},{"key":"9257_CR3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","volume":"353","author":"CN Harrison","year":"2005","unstructured":"Harrison CN, Campel PJ, Buck G, Wheatley K, East CL, Bareford D, et al. United Kingdom Medical Research Council Primary Thrombocythemia 1 Study. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med. 2005;353:33\u201345. doi: 10.1056\/NEJMoa043800 .","journal-title":"N Engl J Med"},{"key":"9257_CR4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.1992.tb01587.x","volume":"48","author":"H Maschek","year":"1992","unstructured":"Maschek H, Georgii A, Katoutsi V, Werner M, Bandecar K, Kressel M-G, et al. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol. 1992;48:208\u201314.","journal-title":"Eur J Haematol"},{"key":"9257_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1385\/MO:21:4:325","volume":"21","author":"D Marisavljevic","year":"2004","unstructured":"Marisavljevic D, Rolovic Z, Cemerikic V, Boskovic D, Colovic M. Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significance. Med Oncol. 2004;21:325\u201331. doi: 10.1385\/MO:21:4:325 .","journal-title":"Med Oncol"},{"key":"9257_CR6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V13.7.609.609","volume":"13","author":"BA Bouroncle","year":"1958","unstructured":"Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13:609\u201330.","journal-title":"Blood"},{"issue":"Suppl 1","key":"9257_CR7","first-page":"1","volume":"14","author":"BA Bouroncle","year":"1994","unstructured":"Bouroncle BA. Thirty-five years in the progress of hairy cell leukaemia. Leuk Lymphoma. 1994;14(Suppl 1):1\u201312.","journal-title":"Leuk Lymphoma"},{"key":"9257_CR8","first-page":"310","volume":"15","author":"JR Quesada","year":"1984","unstructured":"Quesada JR, Reuben J, Manning JT, et al. Alpha interferon for induction of remission in hairy-cell leukaemia. N Engl J Med. 1984;15:310.","journal-title":"N Engl J Med"},{"key":"9257_CR9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(197405)33:5<1399::AID-CNCR2820330526>3.0.CO;2-E","volume":"33","author":"JS Burke","year":"1974","unstructured":"Burke JS, Byrne GEJ, Rappaport H. Hairy cell leukaemia (leukemic reticuloendotheliosis). A clinical pathologic study of 21 patients. Cancer. 1974;33:1399. doi: 10.1002\/1097-0142(197405)33:5<1399::AID-CNCR2820330526>3.0.CO;2-E .","journal-title":"Cancer"},{"key":"9257_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1979.tb03740.x","volume":"43","author":"A Manoharan","year":"1979","unstructured":"Manoharan A, Horsley R, Pitney WR. The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol. 1979;43:185\u201390. doi: 10.1111\/j.1365-2141.1979.tb03740.x .","journal-title":"Br J Haematol"},{"key":"9257_CR11","first-page":"225","volume":"3","author":"J Thiele","year":"1991","unstructured":"Thiele J, Grashof K, Fischer R. Follow-up study on bone marrow reticulin fibrosis in AML. Anal Cell Pathol. 1991;3:225\u201331.","journal-title":"Anal Cell Pathol"},{"key":"9257_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0145-2126(93)90097-5","volume":"17","author":"A Islam","year":"1993","unstructured":"Islam A. Proposal for a classification of acute myeloid leukaemia based on plastic-embedded bone marrow biopsy sections. Leuk Res. 1993;17:421\u20137.","journal-title":"Leuk Res"},{"key":"9257_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/56.1.24","volume":"56","author":"DE Bauermeister","year":"1971","unstructured":"Bauermeister DE. Quantitation of bone marrow reticulin\u2014a normal range. Am J Clin Pathol. 1971;56:24\u201331.","journal-title":"Am J Clin Pathol"},{"key":"9257_CR14","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Fachetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128\u201332.","journal-title":"Haematologica"},{"key":"9257_CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1042\/bj2350903","volume":"235","author":"EA Balazs","year":"1986","unstructured":"Balazs EA, Laurent TC, Jeanloz RW. Nomenclature of hyaluronic acid. Biochem J. 1986;235:903.","journal-title":"Biochem J"},{"key":"9257_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","volume":"242","author":"JR Fraser","year":"1997","unstructured":"Fraser JR, Laurent TC, Laurent UB. Hyaluronan. Its nature, distribution, functions and turnover. J Intern Med. 1997;242:27\u201333. doi: 10.1046\/j.1365-2796.1997.00170.x .","journal-title":"J Intern Med"},{"key":"9257_CR17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2796.1997.00171.x","volume":"242","author":"BP Toole","year":"1997","unstructured":"Toole BP. Hyaluronan in morphogenesis. J Intern Med. 1997;242:35. doi: 10.1046\/j.1365-2796.1997.00171.x .","journal-title":"J Intern Med"},{"key":"9257_CR18","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1074\/jbc.R100037200","volume":"277","author":"M Tammi","year":"2002","unstructured":"Tammi M, Day A, Turley E. Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002;277:4581\u20134. doi: 10.1074\/jbc.R100037200 .","journal-title":"J Biol Chem"},{"key":"9257_CR19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1349-7006.2008.00885.x","volume":"99","author":"N Itano","year":"2008","unstructured":"Itano N, Zhuo L, Kimata K. Review article. Impact of the hyaluronan-rich tumour microenvironment on cancer initiation and progression. Cancer Sci. 2008;99:1720\u20135. doi: 10.1111\/j.1349-7006.2008.00885.x .","journal-title":"Cancer Sci"},{"key":"9257_CR20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semcancer.2008.03.005","volume":"18","author":"RH Tammi","year":"2008","unstructured":"Tammi RH, Kultti A, Pirinen R, Kosma VM, Auvinen P, Tammi MI. Hyaluronan in human tumours: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol. 2008;18:288\u201395.","journal-title":"Semin Cancer Biol"},{"key":"9257_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1600-0609.2002.01617.x","volume":"68","author":"G Sundstr\u00f6m","year":"2002","unstructured":"Sundstr\u00f6m G, L\u00f6fvenberg E, Hassan I, Engstr\u00f6m-Laurent A. Localisation and distribution of hyaluronan in normal bone marrow matrix: a novel method to evaluate impending fibrosis? Eur J Haematol. 2002;68:194\u2013202. doi: 10.1034\/j.1600-0609.2002.01617.x .","journal-title":"Eur J Haematol"},{"key":"9257_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/MO:22:1:071","volume":"22","author":"G Sundstr\u00f6m","year":"2005","unstructured":"Sundstr\u00f6m G, Dahl IMS, Hultdin M, Lundstr\u00f6m B, Wahlin A, Engsr\u00f6m-Laurent A. Bone marrow hyaluronan distribution in patients with acute myeloid leukaemia. Med Oncol. 2005;22:71\u20138. doi: 10.1385\/MO:22:1:071 .","journal-title":"Med Oncol"},{"key":"9257_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02685904","volume":"24","author":"M Hultdin","year":"2007","unstructured":"Hultdin M, Sundstr\u00f6m G, Wahlin A, Lundstr\u00f6m B, Samuelsson J, Birgeg\u00e5rd G, et al. Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment. Med Oncol. 2007;24:63\u201370.","journal-title":"Med Oncol"},{"key":"9257_CR24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French\u2013American\u2013British Cooperative Group. Ann Intern Med. 1985;103:620\u20135.","journal-title":"Ann Intern Med"},{"key":"9257_CR25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European\u2013American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood. 1994;84:1361\u201392.","journal-title":"Blood"},{"key":"9257_CR26","volume-title":"Manual of histological staining methods","author":"FA Putt","year":"1972","unstructured":"Putt FA. Manual of histological staining methods. New York: Wiley & Sons; 1972."},{"key":"9257_CR27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0005-2795(79)90158-2","volume":"578","author":"A Tengblad","year":"1979","unstructured":"Tengblad A. Affinity chromatography on immobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage. Biochim Biophys Acta. 1979;578:281\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"9257_CR28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood-2002-05-1344","volume":"101","author":"S Nilsson","year":"2003","unstructured":"Nilsson S, et al. Hyaluronan is synthesized by primitive haematopoietic cells, participates in their lodgement at the endosteum, following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood. 2003;101:856\u201362.","journal-title":"Blood"},{"key":"9257_CR29","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1074\/jbc.R100039200","volume":"277","author":"BP Toole","year":"2002","unstructured":"Toole BP. Hyaluronan\u2013cell interactions in cancer and vascular disease. J Biol Chem. 2002;277:4593\u20136. doi: 10.1074\/jbc.R100039200 .","journal-title":"J Biol Chem"},{"issue":"3","key":"9257_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.stem.2008.02.012","volume":"2","author":"S Khaldoyanidi","year":"2008","unstructured":"Khaldoyanidi S. Directing stem cell homing. Cell Stem Cell. 2008;2(3):198\u2013200. doi: 10.1016\/j.stem.2008.02.012 .","journal-title":"Cell Stem Cell"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9257-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9257-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T23:19:51Z","timestamp":1589930391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9257-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,23]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9257"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9257-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,23]]}}}